Home › NDC Lookup › RxCUI directory › RxCUI 904447

Alendronic acid 0.933 MG/ML Oral Solution — RxCUI 904447

RxNorm drug concept · Semantic clinical drug
RxCUI 904447 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI904447
Official nameAlendronic acid 0.933 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asalendronic acid 70 MG per 75 ML Oral Solution; alendronate sodium 70 MG in 75 mL Oral Solution; alendronic acid 70 MG (as alendronate sodium 91.35 mg) per 75 ML Oral Solution
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,451 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Alendronate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It strengthens bone and lowers fracture risk in osteoporosis. Some products are also used for steroid-induced osteoporosis and Paget's disease of bone. Your pharmacy label shows wh...
  • Take it first thing in the morning with a full glass of plain water, at least 30 minutes before food, drinks or other medicines. Stay upright for at least 30 minutes and until you...
  • Stomach upset, heartburn, nausea, constipation or diarrhea, and some bone or muscle aches can happen. Stop and call your doctor if you have trouble or pain swallowing, chest pain,...
  • What side effects are normal, and when should I call?
📖 Read our full Alendronate guide →

🕸️ Concept Web — How Alendronic acid 0.933 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Alendronic acid 0.933 MG/ML Oral Solution RxCUI 904447

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Alendronate 46041
    • Alendronic acid 236083
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Alendronate Oral Solution 904446
    • Alendronic acid Oral Solution 2647408
    • Alendronate Oral Liquid Product 1367008
    • Alendronate Oral Product 1367010
    • Alendronic acid Oral Liquid Product 2659453
    • Alendronic acid Oral Product 2662744
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Alendronic acid 0.933 MG/ML 904445

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Alendronic acid 0.933 MG/ML SCDC · 904445
  • Alendronate Oral Solution SCDF · 904446
  • Alendronic acid Oral Solution SCDFP · 2647408
  • Alendronate Oral Liquid Product SCDG · 1367008
  • Alendronate Oral Product SCDG · 1367010
  • Alendronic acid Oral Liquid Product SCDGP · 2659453
  • Alendronic acid Oral Product SCDGP · 2662744

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 904447 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0282-59 4 BOTTLE, UNIT-DOSE in 1 CARTON (0054-0282-59) / 75 mL in 1... Alendronate Sodium Hikma Pharmaceuticals USA Inc. 2020-10-30
70954-0264-10 4 BOTTLE in 1 CARTON (70954-264-10) / 75 mL in 1 BOTTLE Alendronate Sodium ANI Pharmaceuticals, Inc. 2023-05-24
Observed labelers: ANI Pharmaceuticals, Inc. (1) · Hikma Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.6552
Range $0.6552–$0.6552 · middle 50% $0.6552–$0.6552 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.